John Mahama has been sworn in for a second term as Ghana’s president at a ceremony in the capital Accra, with around 20 African leaders in attendance. Mahama won 56 percent of the vote in the ...

It’s free, but you have to watch the occasional block of ads. It’s worth it, though, for these John Wick movies, which are some of the best action movies ever made. Any action movie fan will ...

VANCOUVER, BC, Jan. 30, 2025 /CNW/ - Power Metals Corp ("Power Metals" or the "Company") (TSXV: PWM) (FRANKFURT: OAA1) (OTCQB: PWRMF) is pleased to announce the appointment of Canaccord Genuity ...

We are witnessing a transformative era in energy investments “that looks and feels a lot like the communications revolution several decades ago,” said George Gianarikas, Canaccord Genuity ...

John Travolta, just like Olivia Newton-John, skyrocketed to fame following the release of the film musical Grease in 1978, the year after he danced his way across the big screen in Saturday Night ...

In a report released yesterday, Alex Brooks from Canaccord Genuity reiterated a Buy rating on eEnergy Group (EAAS – Research Report), with a price target of p12.00. The company’s shares opened ...

As of January 29, 2025, the average one-year price target for Dave is $112.35/share. The forecasts range from a low of $90.90 to a high of $141.75. The average price target represents an increase ...

Canaccord raised the firm’s price target on Corcept Therapeutics (CORT) to $130 from $78 and keeps a Buy rating on the shares. The firm is pounding the table on Corcept Therapeutics because of ...

(Sharecast News) - Analysts at Canaccord Genuity raised their target price on home improvement retailer Wickes from 180.0p to 198.0p on Wednesday as a "resilient" Q4 performance drove an upgrade ...

Canaccord Genuity is seeking a bigger slice of the action in local technology M&A, with a hot recruit in its investment bank. Canaccord Genuity has made a bunch of new hires in its equity research ...

(Sharecast News) - Canaccord Genuity maintained its price target on Antofagasta on Monday at 2,065p on the back of improving year-on-year profit trends in 2025. It also lifted its rating on the ...

Canaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as $3 if a key trial succeeds. But the broker said that with a successful Phase III trial, that ...